3-Methanesulfonylbenzoic acid → N-[5-(3-furyl)[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(methylsulfonyl)benzamide
Reaktionsgleichung
[O:1]1[CH:5]=[CH:4][C:3]([C:6]2[N:11]3[N:12]=[C:13]([NH2:15])[N:14]=[C:10]3[CH:9]=[CH:8][CH:7]=2)=[CH:2]1.[CH3:16][S:17]([C:20]1[CH:21]=[C:22]([CH:26]=[CH:27][CH:28]=1)[C:23](O)=[O:24])(=[O:19])=[O:18]>>[O:1]1[CH:5]=[CH:4][C:3]([C:6]2[N:11]3[N:12]=[C:13]([NH:15][C:23](=[O:24])[C:22]4[CH:26]=[CH:27][CH:28]=[C:20]([S:17]([CH3:16])(=[O:19])=[O:18])[CH:21]=4)[N:14]=[C:10]3[CH:9]=[CH:8][CH:7]=2)=[CH:2]1Komponenten
3
Versuchsvorschrift
The title compound was prepared following procedure described for example 2, but starting from 5-(3-furyl)[1,2,4]triazolo[1,5-a]pyridin-2-amine ((A2), 50 mg; 0.25 mmol; 1.0 eq.) and 3-methylsulphonylbenzoic acid (60 mg, 0.3 mmol, 1.2 eq.) as an off-white solid (9 mg, 9%). HPLC, Rt: 2.79 min. (purity 96.5%). LC/MS, M+(ESI): 383.0, M−(ESI): 381.0.
Quellen und Nachweise
- ORD-Eintrag
- ord-74ec2d0f3467499dba47d986ac2c3b3f
- Quelldatensatz
- uspto-grants-2012_09
- Patentnummer
- US08263595B2
Notizen zur Reaktion
Wird geladen…